We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Apparent mineralocorticoid excess in Israel: a case series and literature review.
- Authors
Lebel, Asaf; Shalom, Efrat Ben; Mokatern, Rozan; Halevy, Raphael; Zehavi, Yoav; Magen, Daniela
- Abstract
Background and Objective Apparent mineralocorticoid excess (AME) syndrome is an ultra-rare autosomal-recessive tubulopathy, caused by mutations in HSD11B2 , leading to excessive activation of the kidney mineralocorticoid receptor, and characterized by early-onset low-renin hypertension, hypokalemia, and risk of chronic kidney disease (CKD). To date, most reports included few patients, and none described patients from Israel. We aimed to describe AME patients from Israel and to review the relevant literature. Design Retrospective cohort study. Methods Clinical, laboratory, and molecular data from patients' records were collected. Results Five patients presented at early childhood with normal estimated glomerular filtration rate (eGFR), while 2 patients presented during late childhood with CKD. Molecular analysis revealed 2 novel homozygous mutations in HSD11B2. All patients presented with severe hypertension and hypokalemia. While all patients developed nephrocalcinosis, only 1 showed hypercalciuria. All individuals were managed with potassium supplements, mineralocorticoid receptor antagonists, and various antihypertensive medications. One patient survived cardiac arrest secondary to severe hyperkalemia. At last follow-up, those 5 patients who presented early exhibited normal eGFR and near-normal blood pressure, but 2 have hypertension complications. The 2 patients who presented with CKD progressed to end-stage kidney disease (ESKD) necessitating dialysis and kidney transplantation. Conclusions In this 11-year follow-up report of 2 Israeli families with AME, patients who presented early maintained long-term normal kidney function, while those who presented late progressed to ESKD. Nevertheless, despite early diagnosis and management, AME is commonly associated with serious complications of the disease or its treatment.
- Subjects
ISRAEL; HYPOKALEMIA; LITERATURE reviews; HYPERKALEMIA; CHRONIC kidney failure; MINERALOCORTICOID receptors; DISEASE risk factors; GLOMERULAR filtration rate
- Publication
European Journal of Endocrinology, 2024, Vol 190, Issue 5, p347
- ISSN
0804-4643
- Publication type
Article
- DOI
10.1093/ejendo/lvae049